Physician profile
Perry S Brown
NPI 1720024060
$655.90
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $35.00 · 2021: $40.98 · 2022: $155 · 2023: $88.63 · 2024: $16.61 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $150.00 | 2025 | Relizorb |
| Vertex Pharmaceuticals Incorporated | $136.14 | 2019-2025 | Kalydeco, Trikafta |
| Mylan Specialty L.P. | $130.04 | 2022-2023 | Tobi Podhaler |
| Abbvie INC. | $114.90 | 2019-2022 | |
| Pari Respiratory Equipment, INC. | $23.27 | 2020 | |
| Advanced Respiratory, INC | $20.49 | 2019 | |
| Digestive Care, INC. | $19.76 | 2023 | Pertzye |
| Insmed, INC. | $19.00 | 2019 | |
| Baxter Healthcare | $16.61 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Gilead Sciences, INC. | $14.89 | 2019 | |
| Allergan, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.